Clarus Therapeutics
Signal active
Organization
Contact Information
Overview
Clarus Therapeutics is a biopharmaceutical company that develops androgen-based medicines for men and women. It offers OriTex, a proprietary oral testosterone product for use in men with low testosterone levels.
About
Industries
Biotechnology, Life Science, Health Care, Therapeutics
Founded
2003
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Clarus Therapeutics headquartered in United States, North America, operates in the Biotechnology, Life Science, Health Care, Therapeutics sector. The company focuses on Biotechnology and has secured $15.6B in funding across 128 round(s). With a team of 11-50 employees, Clarus Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Clarus Therapeutics, raised $31.5M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
8
Investors
1
Lead Investors
0
Total Funding Amount
$122.0M
Details
3
Clarus Therapeutics has raised a total of $122.0M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2006 | Early Stage Venture | |||
| 2004 | Early Stage Venture | 2.5M | ||
| 2007 | Late Stage Venture | 8.0M |
Investors
Clarus Therapeutics is funded by 21 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Thomas, McNerney & Partners | - | FUNDING ROUND - Thomas, McNerney & Partners | 8.0M |
| Mengjiao Jiang | - | FUNDING ROUND - Mengjiao Jiang | 31.5M |
| Clarus Therapeutics | - | FUNDING ROUND - Clarus Therapeutics | 31.5M |
| C-Bridge Capital | - | FUNDING ROUND - C-Bridge Capital | 31.5M |
Recent Activity
There is no recent news or activity for this profile.